1. Elea
  2. Dipartimenti e Centri di ricerca UniSA. Pubblicazioni scientifiche
  3. Translational Medicine @ UniSa
  4. Translational Medicine @ UniSa. Volume 14 (jan.-apr. 2016)
Utilizza questo identificativo per citare o creare un link a questo documento: http://elea.unisa.it/xmlui/handle/10556/3785
Record completo di tutti i metadati
Campo DCValoreLingua
dcterms.contributor.authorGalasso, Gennaro
dcterms.contributor.authorMirra, M.
dcterms.contributor.authorDe Luca, G.
dcterms.contributor.authorPiscione, Federico
dc.date.accessioned2019-11-07T14:54:51Z
dc.date.available2019-11-07T14:54:51Z
dcterms.date.issued2016
dcterms.identifier.citationGalasso G, Mirra M, De Luca G, Piscione F. Bivalirudin in patients undergoing pci: state of art and future perspectives. Translational Medicine @ UniSa 2016, 14(9): 57-66it_IT
dcterms.identifier.issn2239-9747it_IT
dcterms.identifier.urihttp://elea.unisa.it:8080/xmlui/handle/10556/3785
dcterms.identifier.urihttp://dx.doi.org/10.14273/unisa-2007
dc.description.abstractAcute coronary syndrome (ACS) represents the most common cause of death worldwide. Percutaneous coronary intervention (PCI) is the management of choice in patients with ACS and occurrence of intra procedural thrombotic complications are an independent predictor of mortality and other major adverse cardiovascular events in patients undergoing PCI. According to current guideline, anticoagulation therapy is indicated during PCI in order to reduce the risk of thrombotic complications such as stent thrombosis. Among currently available anticoagulant drugs, bivalirudin demonstrates a lower incidence of bleeding risk, despite it is associated with an increased risk of stent thrombosis. The aim of this paper is to discuss the pharmacology of bivalirudin and the clinical evidences of its use in patients undergoing PCI for ACS.it_IT
dcterms.format.extentP. 57-66it_IT
dc.language.isoenit_IT
dcterms.sourceUniSa. Sistema Bibliotecario di Ateneoit_IT
dcterms.subjectBivalirudinit_IT
dcterms.subjectAnticoagulantit_IT
dcterms.subjectPercutaneous coronary interventionit_IT
dcterms.subjectMyocardial infarctionit_IT
dcterms.subjectBleedingit_IT
dcterms.titleBivalirudin in patients undergoing pci: state of art and future perspectivesit_IT
dcterms.typeJournal Articleit_IT
È visualizzato nelle collezioni:Translational Medicine @ UniSa. Volume 14 (jan.-apr. 2016)

File in questo documento:
Non ci sono file allegati a questo documento
Visualizza la scheda semplice del documento SFX Query


Tutti i documenti archiviati in DSpace sono protetti da copyright. Tutti i diritti riservati.